Mission Statement
The Boulder BioScience mission is to advance breakthrough science into first-in-class therapeutics for unmet needs in the treatment of Brain Injury. The Boulder BioScience Drug Candidates provide new treatments for Ischemic Stroke and Traumatic Brain Injury.
Boulder BioScience has discovered new therapeutic uses for a pleiotropic small molecule API which provides neuroprotection, inhibits neutrophil activation, modifies arterial thrombosis, and provides a new therapeutic tool to control acute neuro-inflammation.